UniProt ID | SF01_HUMAN | |
---|---|---|
UniProt AC | Q15637 | |
Protein Name | Splicing factor 1 | |
Gene Name | SF1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 639 | |
Subcellular Localization | Nucleus. | |
Protein Description | Necessary for the ATP-dependent first step of spliceosome assembly. Binds to the intron branch point sequence (BPS) 5'-UACUAAC-3' of the pre-mRNA. May act as transcription repressor.. | |
Protein Sequence | MATGANATPLDFPSKKRKRSRWNQDTMEQKTVIPGMPTVIPPGLTREQERAYIVQLQIEDLTRKLRTGDLGIPPNPEDRSPSPEPIYNSEGKRLNTREFRTRKKLEEERHNLITEMVALNPDFKPPADYKPPATRVSDKVMIPQDEYPEINFVGLLIGPRGNTLKNIEKECNAKIMIRGKGSVKEGKVGRKDGQMLPGEDEPLHALVTANTMENVKKAVEQIRNILKQGIETPEDQNDLRKMQLRELARLNGTLREDDNRILRPWQSSETRSITNTTVCTKCGGAGHIASDCKFQRPGDPQSAQDKARMDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPRPAAPANNPPPPSLMSTTQSRPPWMNSGPSESRPYHGMHGGGPGGPGGGPHSFPHPLPSLTGGHGGHPMQHNPNGPPPPWMQPPPPPMNQGPHPPGHHGPPPMDQYLGSTPVGSGVYRLHQGKGMMPPPPMGMMPPPPPPPSGQPPPPPSGPLPPWQQQQQQPPPPPPPSSSMASSTPLPWQQNTTTTTTSAGTGSIPPWQQQQAAAAASPGAPQMQGNPTMVPLPPGVQPPLPPGAPPPPPPPPPGSAGMMYAPPPPPPPPMDPSNFVTMMGMGVAGMPPFGMPPAPPPPPPQN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MATGANATP ------CCCCCCCCC | 18.10 | 22223895 | |
3 | Phosphorylation | -----MATGANATPL -----CCCCCCCCCC | 35.21 | 27251275 | |
8 | Phosphorylation | MATGANATPLDFPSK CCCCCCCCCCCCCCH | 24.96 | 29255136 | |
8 (in isoform 5) | Phosphorylation | - | 24.96 | 22199227 | |
14 | Phosphorylation | ATPLDFPSKKRKRSR CCCCCCCCHHHCCCC | 51.29 | 29255136 | |
15 | Ubiquitination | TPLDFPSKKRKRSRW CCCCCCCHHHCCCCC | 57.76 | - | |
15 | Acetylation | TPLDFPSKKRKRSRW CCCCCCCHHHCCCCC | 57.76 | 25953088 | |
16 | Ubiquitination | PLDFPSKKRKRSRWN CCCCCCHHHCCCCCC | 68.44 | - | |
20 | Phosphorylation | PSKKRKRSRWNQDTM CCHHHCCCCCCCCHH | 44.69 | 17287340 | |
26 | Phosphorylation | RSRWNQDTMEQKTVI CCCCCCCHHHCCCCC | 16.91 | 28450419 | |
31 | Phosphorylation | QDTMEQKTVIPGMPT CCHHHCCCCCCCCCC | 24.30 | 21406692 | |
36 | Sulfoxidation | QKTVIPGMPTVIPPG CCCCCCCCCCCCCCC | 1.79 | 28183972 | |
38 | Phosphorylation | TVIPGMPTVIPPGLT CCCCCCCCCCCCCCC | 23.36 | 21406692 | |
45 | Phosphorylation | TVIPPGLTREQERAY CCCCCCCCHHHHHEE | 37.77 | 21406692 | |
62 | Phosphorylation | QLQIEDLTRKLRTGD EEEHHHHHHHHHCCC | 37.77 | 26074081 | |
67 | Phosphorylation | DLTRKLRTGDLGIPP HHHHHHHCCCCCCCC | 45.55 | 22167270 | |
80 | Phosphorylation | PPNPEDRSPSPEPIY CCCCCCCCCCCCCCC | 41.89 | 19664994 | |
80 (in isoform 2) | Phosphorylation | - | 41.89 | 18669648 | |
82 | Phosphorylation | NPEDRSPSPEPIYNS CCCCCCCCCCCCCCC | 43.04 | 19664994 | |
82 (in isoform 2) | Phosphorylation | - | 43.04 | 18669648 | |
87 | Phosphorylation | SPSPEPIYNSEGKRL CCCCCCCCCCCCCCC | 24.29 | 22167270 | |
87 (in isoform 2) | Phosphorylation | - | 24.29 | 18669648 | |
89 | Phosphorylation | SPEPIYNSEGKRLNT CCCCCCCCCCCCCCH | 30.65 | 22167270 | |
89 (in isoform 2) | Phosphorylation | - | 30.65 | 18669648 | |
92 | Acetylation | PIYNSEGKRLNTREF CCCCCCCCCCCHHHH | 50.05 | 25953088 | |
96 | O-linked_Glycosylation | SEGKRLNTREFRTRK CCCCCCCHHHHHHHH | 35.85 | 30059200 | |
112 (in isoform 5) | Phosphorylation | - | 4.13 | 30266825 | |
130 | Acetylation | FKPPADYKPPATRVS CCCCCCCCCCCCCCC | 45.10 | 25953088 | |
134 | Phosphorylation | ADYKPPATRVSDKVM CCCCCCCCCCCCCEE | 37.06 | 28348404 | |
137 | Phosphorylation | KPPATRVSDKVMIPQ CCCCCCCCCCEECCC | 28.55 | 28348404 | |
145 (in isoform 5) | Phosphorylation | - | 52.63 | 27251275 | |
151 (in isoform 5) | Phosphorylation | - | 24.72 | 27251275 | |
165 | Acetylation | GPRGNTLKNIEKECN CCCCCHHHHHHHHHC | 54.57 | 27452117 | |
169 | Acetylation | NTLKNIEKECNAKIM CHHHHHHHHHCCEEE | 64.86 | 25953088 | |
174 | Ubiquitination | IEKECNAKIMIRGKG HHHHHCCEEEECCCC | 20.86 | - | |
174 | Acetylation | IEKECNAKIMIRGKG HHHHHCCEEEECCCC | 20.86 | 25953088 | |
205 (in isoform 5) | Phosphorylation | - | 16.06 | 27251275 | |
207 (in isoform 5) | Phosphorylation | - | 5.01 | 27251275 | |
208 | Phosphorylation | EPLHALVTANTMENV CCHHHHHCHHHHHHH | 18.29 | 25332170 | |
217 | Acetylation | NTMENVKKAVEQIRN HHHHHHHHHHHHHHH | 54.07 | 20167786 | |
217 | Ubiquitination | NTMENVKKAVEQIRN HHHHHHHHHHHHHHH | 54.07 | - | |
227 | Ubiquitination | EQIRNILKQGIETPE HHHHHHHHCCCCCCC | 42.56 | 22053931 | |
227 (in isoform 2) | Ubiquitination | - | 42.56 | 21890473 | |
227 (in isoform 6) | Ubiquitination | - | 42.56 | 21890473 | |
227 | Ubiquitination | EQIRNILKQGIETPE HHHHHHHHCCCCCCC | 42.56 | 21890473 | |
227 | Acetylation | EQIRNILKQGIETPE HHHHHHHHCCCCCCC | 42.56 | 25953088 | |
227 (in isoform 1) | Ubiquitination | - | 42.56 | 21890473 | |
227 (in isoform 3) | Ubiquitination | - | 42.56 | 21890473 | |
227 (in isoform 4) | Ubiquitination | - | 42.56 | 21890473 | |
232 | Phosphorylation | ILKQGIETPEDQNDL HHHCCCCCCCCHHHH | 30.02 | 29255136 | |
253 | Phosphorylation | ELARLNGTLREDDNR HHHHHHCCCCCCCCC | 22.90 | 25159151 | |
263 | Methylation | EDDNRILRPWQSSET CCCCCCCCCCCCCCC | 28.21 | 115916541 | |
267 | Phosphorylation | RILRPWQSSETRSIT CCCCCCCCCCCCCCC | 26.69 | 28450419 | |
268 | Phosphorylation | ILRPWQSSETRSITN CCCCCCCCCCCCCCC | 28.08 | 28450419 | |
270 | Phosphorylation | RPWQSSETRSITNTT CCCCCCCCCCCCCCE | 31.50 | 27251275 | |
272 | Phosphorylation | WQSSETRSITNTTVC CCCCCCCCCCCCEEE | 40.98 | 28450419 | |
274 | Phosphorylation | SSETRSITNTTVCTK CCCCCCCCCCEEECC | 27.97 | 28450419 | |
276 | Phosphorylation | ETRSITNTTVCTKCG CCCCCCCCEEECCCC | 16.38 | 28450419 | |
277 | Phosphorylation | TRSITNTTVCTKCGG CCCCCCCEEECCCCC | 18.69 | 28450419 | |
280 | Phosphorylation | ITNTTVCTKCGGAGH CCCCEEECCCCCCCC | 25.65 | 28450419 | |
281 | Acetylation | TNTTVCTKCGGAGHI CCCEEECCCCCCCCC | 26.25 | 25953088 | |
282 | S-palmitoylation | NTTVCTKCGGAGHIA CCEEECCCCCCCCCC | 3.07 | 21044946 | |
292 | S-palmitoylation | AGHIASDCKFQRPGD CCCCCCCCCCCCCCC | 4.39 | 21044946 | |
293 | Acetylation | GHIASDCKFQRPGDP CCCCCCCCCCCCCCC | 49.90 | 25953088 | |
302 | Phosphorylation | QRPGDPQSAQDKARM CCCCCCCHHHHHHHC | 33.03 | 25022875 | |
306 | Acetylation | DPQSAQDKARMDKEY CCCHHHHHHHCCHHH | 26.30 | 23749302 | |
306 | Ubiquitination | DPQSAQDKARMDKEY CCCHHHHHHHCCHHH | 26.30 | - | |
306 | 2-Hydroxyisobutyrylation | DPQSAQDKARMDKEY CCCHHHHHHHCCHHH | 26.30 | - | |
313 | Phosphorylation | KARMDKEYLSLMAEL HHHCCHHHHHHHHHH | 13.82 | - | |
315 | O-linked_Glycosylation | RMDKEYLSLMAELGE HCCHHHHHHHHHHCC | 18.39 | 30059200 | |
328 | O-linked_Glycosylation | GEAPVPASVGSTSGP CCCCCCCCCCCCCCC | 22.42 | 30059200 | |
331 | O-linked_Glycosylation | PVPASVGSTSGPATT CCCCCCCCCCCCCCC | 19.76 | 30059200 | |
332 | O-linked_Glycosylation | VPASVGSTSGPATTP CCCCCCCCCCCCCCC | 31.60 | 30059200 | |
333 | O-linked_Glycosylation | PASVGSTSGPATTPL CCCCCCCCCCCCCCC | 44.47 | 30059200 | |
337 | O-linked_Glycosylation | GSTSGPATTPLASAP CCCCCCCCCCCCCCC | 31.89 | 30059200 | |
337 | Phosphorylation | GSTSGPATTPLASAP CCCCCCCCCCCCCCC | 31.89 | 28348404 | |
338 | Phosphorylation | STSGPATTPLASAPR CCCCCCCCCCCCCCC | 20.57 | 28348404 | |
338 | O-linked_Glycosylation | STSGPATTPLASAPR CCCCCCCCCCCCCCC | 20.57 | 30059200 | |
342 | O-linked_Glycosylation | PATTPLASAPRPAAP CCCCCCCCCCCCCCC | 46.63 | 30059200 | |
345 | Dimethylation | TPLASAPRPAAPANN CCCCCCCCCCCCCCC | 32.95 | - | |
345 | Methylation | TPLASAPRPAAPANN CCCCCCCCCCCCCCC | 32.95 | 55533399 | |
352 (in isoform 5) | Ubiquitination | - | 53.19 | 21890473 | |
357 (in isoform 5) | Phosphorylation | - | 42.34 | 27251275 | |
365 | Dimethylation | LMSTTQSRPPWMNSG HHCCCCCCCCCCCCC | 31.33 | - | |
365 | Methylation | LMSTTQSRPPWMNSG HHCCCCCCCCCCCCC | 31.33 | 52718103 | |
392 (in isoform 5) | Phosphorylation | - | 49.98 | 27251275 | |
397 (in isoform 5) | Phosphorylation | - | 6.15 | 27251275 | |
427 (in isoform 5) | Phosphorylation | - | 27.53 | 27251275 | |
454 (in isoform 6) | Ubiquitination | - | 21.86 | 21890473 | |
455 (in isoform 6) | Phosphorylation | - | 30.12 | - | |
463 (in isoform 5) | Phosphorylation | - | 1.61 | 27251275 | |
463 (in isoform 6) | Phosphorylation | - | 1.61 | 25159151 | |
466 (in isoform 6) | Phosphorylation | - | 20.10 | 28152594 | |
467 (in isoform 6) | Methylation | - | 36.74 | 24129315 | |
521 | O-linked_Glycosylation | SSSMASSTPLPWQQN CCCCCCCCCCCCCCC | 26.75 | 30059200 | |
522 (in isoform 6) | Phosphorylation | - | 38.07 | - | |
529 (in isoform 4) | Phosphorylation | - | 22.60 | 26434776 | |
539 (in isoform 6) | Phosphorylation | - | 23.74 | 26714015 | |
606 (in isoform 2) | Phosphorylation | - | 45.65 | 26714015 | |
615 (in isoform 3) | Phosphorylation | - | 1.51 | 22798277 | |
654 (in isoform 5) | Phosphorylation | - | 26434776 | ||
662 (in isoform 5) | Methylation | - | - | ||
670 (in isoform 5) | Methylation | - | - |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SF01_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-80; SER-82; TYR-87 AND SER-89, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80 AND SER-82, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-80; SER-82; TYR-87 AND SER-89, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80; SER-82 AND SER-89,PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-463 (ISOFORM 6), ANDMASS SPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-20; SER-80; SER-82 ANDTYR-87, AND MASS SPECTROMETRY. | |
"Toward a global characterization of the phosphoproteome in prostatecancer cells: identification of phosphoproteins in the LNCaP cellline."; Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S.; Electrophoresis 28:2027-2034(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80 AND SER-82, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80 AND SER-82, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80 AND SER-82, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80 AND SER-82, AND MASSSPECTROMETRY. | |
"Phosphorylation of splicing factor SF1 on Ser20 by cGMP-dependentprotein kinase regulates spliceosome assembly."; Wang X., Bruderer S., Rafi Z., Xue J., Milburn P.J., Kraemer A.,Robinson P.J.; EMBO J. 18:4549-4559(1999). Cited for: PROTEIN SEQUENCE OF 19-28; 94-103; 228-239 AND 298-308, FUNCTION,INTERACTION WITH U2AF2, MUTAGENESIS OF SER-20, AND PHOSPHORYLATION ATSER-20. |